当前位置:科学网首页 > 小柯机器人 >详情
双向表观遗传编辑揭示基因调控的层次结构
作者:小柯机器人 发布时间:2024/5/21 16:35:02

美国斯坦福大学Howard Y. Chang小组发现,双向表观遗传编辑揭示基因调控的层次结构。该项研究成果于2024年5月17日在线发表在《自然—生物技术》杂志上。

研究人员开发了一种名为CRISPRai的双向表观遗传编辑系统,在该系统中,研究人员对同一细胞中的两个位点同时施加激活(CRISPRa)和抑制(CRISPRi)扰动。研究人员开发了CRISPRai Perturb-seq,将双扰动gRNA检测与单细胞RNA测序结合起来,从而能够研究混合单细胞群体中的集合扰动。研究人员应用这一平台研究了两种造血系转录因子SPI1和GATA1之间的遗传相互作用,发现了它们对下游靶基因共同调控的新特点,包括SPI1和GATA1在通过不同模式调控的基因上的占有率差异。
 
研究人员还揭示了Jurkat T细胞、原代T细胞和嵌合抗原受体(CAR)T细胞中IL2(白细胞介素-2)的调控图谱,并阐明了增强子介导的IL2基因调控机制。CRISPRai有助于研究特定环境下的基因相互作用,为基因调控提供了新的见解,并将有助于探索非编码疾病相关变体。

据悉,CRISPR扰动方法在研究非编码元件和基因相互作用方面能力有限。

附:英文原文

Title: Bidirectional epigenetic editing reveals hierarchies in gene regulation

Author: Pacalin, Naomi M., Steinhart, Zachary, Shi, Quanming, Belk, Julia A., Dorovskyi, Dmytro, Kraft, Katerina, Parker, Kevin R., Shy, Brian R., Marson, Alexander, Chang, Howard Y.

Issue&Volume: 2024-05-17

Abstract: CRISPR perturbation methods are limited in their ability to study non-coding elements and genetic interactions. In this study, we developed a system for bidirectional epigenetic editing, called CRISPRai, in which we apply activating (CRISPRa) and repressive (CRISPRi) perturbations to two loci simultaneously in the same cell. We developed CRISPRai Perturb-seq by coupling dual perturbation gRNA detection with single-cell RNA sequencing, enabling study of pooled perturbations in a mixed single-cell population. We applied this platform to study the genetic interaction between two hematopoietic lineage transcription factors, SPI1 and GATA1, and discovered novel characteristics of their co-regulation on downstream target genes, including differences in SPI1 and GATA1 occupancy at genes that are regulated through different modes. We also studied the regulatory landscape of IL2 (interleukin-2) in Jurkat T cells, primary T cells and chimeric antigen receptor (CAR) T cells and elucidated mechanisms of enhancer-mediated IL2 gene regulation. CRISPRai facilitates investigation of context-specific genetic interactions, provides new insights into gene regulation and will enable exploration of non-coding disease-associated variants.

DOI: 10.1038/s41587-024-02213-3

Source: https://www.nature.com/articles/s41587-024-02213-3

期刊信息

Nature Biotechnology:《自然—生物技术》,创刊于1996年。隶属于施普林格·自然出版集团,最新IF:68.164
官方网址:https://www.nature.com/nbt/
投稿链接:https://mts-nbt.nature.com/cgi-bin/main.plex